Follow-up... this will not be an issue for the trial. The volunteer was taking the placebo and not the vaccine.
Volunteer, 28, in trial of Oxford Uni vaccine dies ‘of Covid-19 after taking placebo’
Dr João Pedro Feitosa has been named and pictured in local media as it is revealed he was in the placebo group of the AstraZeneca clinical trial of the Covid-19 vaccine, being co-developed by Oxford University
https://www.mirror.co.uk/news/uk-news/volunteer-trial-oxford-uni-vaccine-22885080
The volunteer who died in a clinical trial of the Oxford University Covid-19 vaccine has been named as Dr João Pedro Feitosa.
The 28-year-old medic, pictured in local media, was taking part in
AstraZeneca's trial in Brazil, and was not given the vaccine but a benign placebo, it has been revealed tonight.
It is reported Dr Feitosa died from complications from
coronavirus while taking part in the trial of the potential vaccine, but the pharmaceutical giant would not comment on his death.
AstraZeneca is developing the vaccine with Oxford University in the UK.
Local news site
Diario do Nordeste reports Dr Feitosa was a recently graduated Brazilian doctor who lived in Rio de Janeiro.
Dr João Pedro Feitosa was just 28-years-old
Brazil's health authority, Anvisa, was reportedly told of the death on Monday. It said testing would continue in the trial.
Sources close to the trial said Dr Feitosa had not been given the vaccine, but a benign placebo,
the Sun reports. It remains unclear how he contracted the bug.
Neither Anvisa nor AstraZeneca would comment on the specifics of the case, and Oxford University earlier said there were no concerns around the trial.
Anvisa said in a statement: "In relation to the death of the Oxford vaccine testing volunteer, Anvisa was formally informed of this fact on October 19, 2020.